We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Micro and nano plastics release from a single absorbable suture into simulated body fluid
AI summary Read the abstract
Researchers found that absorbable surgical sutures made from polyglycolic acid release significant numbers of micro and nano plastic particles as they dissolve inside the body. A single centimeter of one suture type released over two million tiny plastic particles into simulated body fluid, raising questions about an overlooked source of microplastic exposure in medical settings.
Synthetic polymers are widely used in medical devices and implants where biocompatibility and mechanical strength are key enablers of emerging technologies. One concern that has not been widely studied is the potential of their microplastics (MPs) release. Here we studied the levels of MP debris released following 8-week in vitro tests on three typical polyglycolic acid (PGA) based absorbable sutures (PGA 100, PGA 90 and PGA 75) and two nonabsorbable sutures (polypropylene-PP and polyamide-PA) in simulated body fluid. The MP release levels ranked from PGA 100 > > PGA 90 > PGA 75 > > PP ∼ PA. A typical PGA 100 suture released 0.63 ± 0.087 million micro (MPs > 1 µm) and 1.96 ± 0.04 million nano (NPs, 200-1000 nm) plastic particles per centimeter. In contrast, no MPs were released from the nonabsorbable sutures under the same conditions. PGA that was co-blended with 10-25% L-lactide or epsilon-caprolactone resulted in a two orders of magnitude lower level of MP release. These results underscore the need to assess the release of nano- and microplastics from medical polymers while applied in the human body and to evaluate possible risks to human health.
More Papers Like This
Plastic particles in medicine: A systematic review of exposure and effects to human health
AI summary Read the abstract
Medical plastics including bags, containers, and administration sets release micro- and nanoplastics along with chemical additives that can interact with pharmaceutical constituents, creating an understudied route of direct human exposure. Both primary exposure (during medical treatment) and secondary environmental exposure (from hospital plastic waste disposal) represent potential health hazards.
P.45: Microplastic in surgery: A scoping literature review on the possible impacts posed by microplastics introduced into the body in surgery.
AI summary Read the abstract
This review looked at existing studies on tiny plastic particles (microplastics) that can end up in your body during surgery, shed from IV lines and catheters, floating in operating room air, or worn off from implants and stitches. Researchers found these plastic bits do show up in patient tissue after surgery, but there's still very little research on whether they actually cause harm or affect recovery. Bottom line: this is a real but understudied risk worth more attention, not yet a proven danger.
Microplastics in the surgical environment
AI summary Read the abstract
Researchers quantified and characterized airborne microplastics in a hospital operating theatre and adjoining anaesthetic room over a one-week period. They found an average of 1,924 microplastic particles per cubic meter per day in the theatre during working hours, dominated by polyethylene terephthalate and polypropylene fragments. The study provides novel data on microplastic exposure in surgical environments where single-use plastics are widely used, and no microplastics were detected during non-working hours.
Microplastics in perioperative practice: an emerging concern for surgical safety
AI summary Read the abstract
This review highlights the emerging concern of microplastics in surgical environments, noting that single-use plastic equipment in operating rooms generates microplastic particles that can contaminate surgical sites and patient tissues, calling for greater awareness of MP exposure risks in perioperative settings.
Microplastic injection? Identification and quantification of plastic particles in medical injections
AI summary Read the abstract
Scientists discovered that medical injection solutions (saline and glucose) sold in China contain an average of 895 microplastic particles per kilogram, with some samples reaching 1,840 particles. Unlike microplastics ingested through food, these particles enter the bloodstream directly through IV injection, bypassing the body's digestive barriers. This reveals a previously unrecognized pathway for microplastic exposure that could pose unique health risks for hospitalized patients.
Research digests by email
When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.